About one in eight Americans have tried GLP-1 drugs like Mounjaro, Zepbound and Ozempic — and they’ve shrunken appetites so ...
The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?
Zacks Investment Research on MSN
Are you a value investor? This 1 stock could be the perfect pick
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...
Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi will sell ...
Earlier on December 8, Barclays initiated coverage of GoodRx with an Underweight rating and $3 price target. This decision ...
Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.
VESALIUS-CV was big in 2025, but studies looking at triglycerides, CRISPR, and oral GLP-1s also made the highlight reel.
Trump on Friday announced what the White House described as the largest set of developments to date under his administration’s push to bring prescription drug prices in the United States in line with ...
A. Your doctor was correct that depression and suicidal thoughts do not appear in the official prescribing information for evolocumab (Repatha) or a similar drug, alirocumab (Praluent). Both are ...
Q. I developed severe depression while taking Repatha, the injectable cholesterol lowering drug. It took me a horrible nine months to realize the drug was making me suicidal. If I wasn’t sleeping, I ...
They agreed to charge the U.S. government no more for new drugs than the prices paid by other well-off countries. The agreements will allow state Medicaid programs to access lower prices from the nine ...
Investor's Business Daily on MSN
Dow Jones' Merck, other drugmakers strike drug-pricing bargains with Trump
Dow Jones stock Merck and eight other bellwether pharma companies struck drug-pricing agreements with the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results